Opaleye Management Inc. Nu Cana PLC Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.59 - $1.06 $518,433 - $931,422	-878,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.74 - $3.27 $229,622 - $1.01 Million	-310,300 Reduced 26.1%	878,700 $878,000
Q4 2021 Feb 14, 2022	BUY	$2.02 - $2.9 $1.43 Million - $2.06 Million	709,400 Added 147.91%	1,189,000 $2.83 Million
Q3 2021 Nov 16, 2021	BUY	$1.95 - $2.85 $935,220 - $1.37 Million	479,600 New	479,600 $1.24 Million

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $63.7M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.